State of Wisconsin Investment Board’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-204,400
| Closed | -$1.23M | – | 1770 |
|
|
2019
Q4 | $1.23M | Hold |
204,400
| – | – | ﹤0.01% | 1200 |
|
|
2019
Q3 | $736K | Buy |
204,400
+17,900
| +10% | +$69K | ﹤0.01% | 1212 |
|
|
2019
Q2 | $500K | Buy |
186,500
+4,100
| +2% | +$12.1K | ﹤0.01% | 1327 |
|
|
2019
Q1 | $540K | Buy |
182,400
+41,800
| +30% | +$103K | ﹤0.01% | 1329 |
|
|
2018
Q4 | $224K | Hold |
140,600
| – | – | ﹤0.01% | 1444 |
|
|
2018
Q3 | $517K | Buy |
140,600
+55,600
| +65% | +$166K | ﹤0.01% | 1393 |
|
|
2018
Q2 | $241K | Hold |
85,000
| – | – | ﹤0.01% | 1415 |
|
|
2018
Q1 | $315K | Hold |
85,000
| – | – | ﹤0.01% | 1358 |
|
|
2017
Q4 | $245K | Hold |
85,000
| – | – | ﹤0.01% | 1374 |
|
|
2017
Q3 | $382K | Hold |
85,000
| – | – | ﹤0.01% | 1346 |
|
|
2017
Q2 | $390K | Buy |
+85,000
| New | +$342K | ﹤0.01% | 1337 |
|
|
2015
Q3 | – | Sell |
-500,000
| Closed | -$4.43M | – | 1351 |
|
|
2015
Q2 | $4.43M | Hold |
500,000
| – | – | 0.02% | 883 |
|
|
2015
Q1 | $4.93M | Buy |
+500,000
| New | +$6.24M | 0.02% | 836 |
|
|
2014
Q3 | – | Sell |
-1,028,140
| Closed | -$7.78M | – | 1351 |
|
|
2014
Q2 | $7.78M | Sell |
1,028,140
-1,181,300
| -53% | -$4.71M | 0.03% | 665 |
|
|
2014
Q1 | $7.27M | Sell |
2,209,440
-400,200
| -15% | -$1.4M | 0.03% | 677 |
|
|
2013
Q4 | $8.66M | Buy |
2,609,640
+609,640
| +30% | +$1.77M | 0.03% | 603 |
|
|
2013
Q3 | $6.04M | Buy |
2,000,000
+1,200,000
| +150% | +$8.23M | 0.03% | 720 |
|
|
2013
Q2 | $6.54M | Buy |
+800,000
| New | +$6.11M | 0.03% | 692 |
|
State of Wisconsin Investment Board's ACHN Position: Q1 2020 in Review
State of Wisconsin Investment Board sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 204,400 shares — an estimated $1.23M sold.
State of Wisconsin Investment Board first reported a position in ACHN in Q2 2013 and held it in 18 quarters. The position peaked at $8.66M in Q4 2013. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- State of Wisconsin Investment Board reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- State of Wisconsin Investment Board sold 204,400 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.23M.
- State of Wisconsin Investment Board first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 18 quarters.
- State of Wisconsin Investment Board's Achillion Pharmaceuticals position peaked at $8.66M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.